Global Rapid Microbiology Testing Market 2023
According to the latest research, the global rapid microbiology testing market is poised to grow by USD 3.3 billion during 2023-2029, progressing at a CAGR of 8.6% during the forecast period.
This industry report offers market estimates of the global market, followed by a detailed analysis of the product, method, application, and region. The global market data on rapid microbiology testing can be segmented by product: consumables, instruments, reagents & kits. The instruments segment held the largest share of the global rapid microbiology testing market in 2022 and is anticipated to hold its share during the forecast period. Rapid microbiology testing market is further segmented by method: cellular component-based, growth-based, nucleic acid-based, viability-based, others. Globally, the growth-based segment made up the largest share of the rapid microbiology testing market. Based on application, the rapid microbiology testing market is segmented into: clinical diagnosis, cosmetics and personal care, environmental, food and beverages, pharmaceuticals and biologics, research, others. The clinical segment was the largest contributor to the global rapid microbiology testing market in 2022. On the basis of region, the rapid microbiology testing market also can be divided into: North America, Europe, Asia-Pacific, MEA (Middle East and Africa), Latin America. North America is estimated to account for the largest share of the global rapid microbiology testing market.
The instruments market is further segmented into automated ID and AST systems, mass spectrometers, PCR systems, cytometers, active air samplers, bioluminescence- and fluorescence-based detection systems, others. In 2022, the automated ID and AST systems segment made up the largest share of revenue generated by the rapid microbiology testing market. Furthermore, the reagents & kits market has been categorized into sterility testing reagents & kits, others. Among these, the sterility testing reagents & kits segment was accounted for the highest revenue generator in 2022.
The global rapid microbiology testing market is highly competitive. Key companies profiled in the report include Abbott Laboratories, Becton Dickinson and Company, bioMerieux SA , Bruker Corporation, Charles River Laboratories International Inc., Danaher Corporation, Don Whitley Scientific Limited, Merck KGaA, Neogen Corporation, Quidel Corporation, Rapid Micro Biosystems Inc., Sartorius Group AG, Thermo Fisher Scientific Inc., TSI Incorporated.
The data-centric report focuses on market trends, status and outlook for segments. With comprehensive market assessment across the major geographies, the report is a valuable asset for the existing players, new entrants and the future investors.
Why buy this report?
This industry report offers market estimates of the global market, followed by a detailed analysis of the product, method, application, and region. The global market data on rapid microbiology testing can be segmented by product: consumables, instruments, reagents & kits. The instruments segment held the largest share of the global rapid microbiology testing market in 2022 and is anticipated to hold its share during the forecast period. Rapid microbiology testing market is further segmented by method: cellular component-based, growth-based, nucleic acid-based, viability-based, others. Globally, the growth-based segment made up the largest share of the rapid microbiology testing market. Based on application, the rapid microbiology testing market is segmented into: clinical diagnosis, cosmetics and personal care, environmental, food and beverages, pharmaceuticals and biologics, research, others. The clinical segment was the largest contributor to the global rapid microbiology testing market in 2022. On the basis of region, the rapid microbiology testing market also can be divided into: North America, Europe, Asia-Pacific, MEA (Middle East and Africa), Latin America. North America is estimated to account for the largest share of the global rapid microbiology testing market.
The instruments market is further segmented into automated ID and AST systems, mass spectrometers, PCR systems, cytometers, active air samplers, bioluminescence- and fluorescence-based detection systems, others. In 2022, the automated ID and AST systems segment made up the largest share of revenue generated by the rapid microbiology testing market. Furthermore, the reagents & kits market has been categorized into sterility testing reagents & kits, others. Among these, the sterility testing reagents & kits segment was accounted for the highest revenue generator in 2022.
The global rapid microbiology testing market is highly competitive. Key companies profiled in the report include Abbott Laboratories, Becton Dickinson and Company, bioMerieux SA , Bruker Corporation, Charles River Laboratories International Inc., Danaher Corporation, Don Whitley Scientific Limited, Merck KGaA, Neogen Corporation, Quidel Corporation, Rapid Micro Biosystems Inc., Sartorius Group AG, Thermo Fisher Scientific Inc., TSI Incorporated.
The data-centric report focuses on market trends, status and outlook for segments. With comprehensive market assessment across the major geographies, the report is a valuable asset for the existing players, new entrants and the future investors.
Why buy this report?
- Get a detailed picture of the Global Rapid Microbiology Testing Market
- Identify segments/areas to invest in over the forecast period in the Global Rapid Microbiology Testing Market
- Understand the competitive environment, the market’s leading players
- The market estimate for ease of analysis across scenarios in Excel format.
- Strategy consulting and research support for three months.
- Print authentication provided for the single-user license.
PART 1. SUMMARY
PART 2. INTRODUCTION
Study period
Geographical scope
Market segmentation
PART 3. RAPID MICROBIOLOGY TESTING MARKET OVERVIEW
PART 4. MARKET BREAKDOWN BY PRODUCT
Consumables
Instruments
Reagents & kits
PART 5. MARKET BREAKDOWN BY METHOD
Cellular component-based
Growth-based
Nucleic acid-based
Viability-based
Others
PART 6. MARKET BREAKDOWN BY APPLICATION
Clinical diagnosis
Cosmetics and personal care
Environmental
Food and beverages
Pharmaceuticals and biologics
Research
Others
PART 7. MARKET BREAKDOWN BY REGION
North America
Europe
Asia-Pacific
MEA (Middle East and Africa)
Latin America
PART 8. KEY COMPANIES
Abbott Laboratories
Becton, Dickinson and Company
bioMerieux SA
Bruker Corporation
Charles River Laboratories International, Inc.
Danaher Corporation
Don Whitley Scientific Limited
Merck KGaA
Neogen Corporation
Quidel Corporation
Rapid Micro Biosystems, Inc.
Sartorius Group AG
Thermo Fisher Scientific, Inc.
TSI Incorporated
PART 9. METHODOLOGY
PART 2. INTRODUCTION
Study period
Geographical scope
Market segmentation
PART 3. RAPID MICROBIOLOGY TESTING MARKET OVERVIEW
PART 4. MARKET BREAKDOWN BY PRODUCT
Consumables
Instruments
Reagents & kits
PART 5. MARKET BREAKDOWN BY METHOD
Cellular component-based
Growth-based
Nucleic acid-based
Viability-based
Others
PART 6. MARKET BREAKDOWN BY APPLICATION
Clinical diagnosis
Cosmetics and personal care
Environmental
Food and beverages
Pharmaceuticals and biologics
Research
Others
PART 7. MARKET BREAKDOWN BY REGION
North America
Europe
Asia-Pacific
MEA (Middle East and Africa)
Latin America
PART 8. KEY COMPANIES
Abbott Laboratories
Becton, Dickinson and Company
bioMerieux SA
Bruker Corporation
Charles River Laboratories International, Inc.
Danaher Corporation
Don Whitley Scientific Limited
Merck KGaA
Neogen Corporation
Quidel Corporation
Rapid Micro Biosystems, Inc.
Sartorius Group AG
Thermo Fisher Scientific, Inc.
TSI Incorporated
PART 9. METHODOLOGY
